🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Neoadjuvant Chemoradiotherapy

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site📍 Chicago University of Chicago · Tests: Toripalimab, Carboplatin, Paclitaxel A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site📍 Hangzhou Zeng Jian · Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy A Prospective, Single-Arm Clinical Study of a Dietary Supplement for the Prevention of Acute Radiation-Induced Rectal Injury During Neoadjuvant Chemoradiotherapy for Rectal Cancer NCT07802002NA1 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Tributyrin Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma NCT07595770Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: • Adebrelimab and nab-paclitaxel, carboplatin in Combination With radiotherapy Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer NCT07458529Phase 21 site📍 Beijing Seventh Medical Center of PLA General Hospital · Tests: CRT+PD-1 inhibitor+Probio-M9, CRT+PD-1 inhibitor+placebo Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy NCT05468242Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy, Tislelizumab Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC) NCT07153445Phase 221 sites📍 Alicante📍 Badalona📍 Barcelona Fundación GECP · Tests: Atezolizumab, Paclitaxel, Carboplatin Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002) NCT04807673Phase 31 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Pembrolizumab, Paclitaxel, Cisplatin, neoadjuvant chemoradiotherapy A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma NCT06354530Phase 2, Phase 31 site📍 Chongqing Army Medical Center of PLA · Tests: anlotinib, Thoracic radiotherapy Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. NCT06758830Phase 2, Phase 31 site📍 Vilnius National Cancer Center Affiliate of Vilnius University Hosp… · Tests: Radiation Therapy, Chemoradiotherapy, Consolidation Chemotherapy, Surgery, Part two Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy NCT06687876Phase 22 sites📍 Amsterdam📍 Amsterdam Amsterdam UMC, location VUmc · Tests: Metformin Rectal Cancer CTC Trial NCT07194616NA4 sites📍 Olomouc📍 Olomouc📍 Ostrava University Hospital Ostrava · Tests: Primary Surgery, Neoadjuvant radiochemotherapy and surgery Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC NCT06601309Phase 21 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Serplulimab, Paclitaxel+Cisplatin (Neoadjuvant Chemotherapy), Paclitaxel+Cisplatin(Concurrent Chemoradiotherapy), Radio… Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer NCT06430658Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Tislelizumab (BGB-A317) with chemoradiotherapy DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer NCT06755866NA1 site📍 Kunming Yunnan Cancer Hospital · Tests: The application value of MRI 4D Free Breathing DCE-MRI in the treatment of esophageal cancer Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer NCT06421376Phase 23 sites📍 Anyang📍 Xinxiang📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Cardonilizumab, Chemoradiotherapy ±immunotherapy, Radical surgery Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903) NCT04138212Phase 31 site📍 Zhengzhou Henan Cancer Hospital · Tests: Paclitaxel, Cisplatin, neoadjuvant chemoradiation therapy Hyperthermia With Chemoradiotherapy in Rectal Cancer NCT06831981NA2 sites📍 Tübingen📍 Tübingen University Hospital Tuebingen · Tests: Hyperthermia, Radiotherapy, Chemotherapy with 5-fluorouracil, Consolidation chemotherapy with FOLFOX SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC NCT07198165Phase 21 site📍 Shanghai Ruijin Hospital · Tests: PD-1 inhibitor based immunotherapy Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC NCT06637163Phase 25 sites📍 Shantou📍 Shenyang📍 Shanghai Shanghai Zhongshan Hospital · Tests: Benmelstobart+ Paclitaxel + Carboplatin+ Radiotherapy, Paclitaxel + Carboplatin + Radiotherapy UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer NCT05148767Phase 41 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Neoadjuvant chemoradiotherapy based on irinotecan Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy NCT03734952NA1 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Neoadjuvant Radiotherapy Program:, Neoadjuvant chemotherapy Program, Esophagectomy program:, Postoperative radiotherapy… Folfox+Irinotecan+Chemort In Esophageal Cancer NCT04656041Phase 23 sites📍 Boston📍 Boston📍 Newton Massachusetts General Hospital · Tests: FOLFOX/ nal-IRI, Paclitaxel, Carboplatin, Proton Radiation Therapy Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC NCT06288373Phase 2, Phase 312 sites📍 Hefei📍 Beijing📍 Chongqing Tongji Hospital · Tests: Camrelizumab, Cisplatin, Nab paclitaxel, Radical surgery, external beam radiation therapy (EBRT) + brachytherapy THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy NCT04815694NA1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: RT Dose escalation in LARC patients with an Early Regression Index > 13.1 at second week on nCRT Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma NCT07277439Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Radiochemoimmunotherapy, Immunomodulation A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer NCT07527026Phase 21 site📍 Beijing Chinese PLA General Hospital · Tests: Camrelizumab Exosomes in Rectal Cancer NCT03874559n/a1 site📍 Kansas City University of Kansas Medical Center · Tests: Blood Draw Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer NCT03712774n/a1 site📍 Munich Ludwig-Maximilians - University of Munich · Tests: EORTC QLQ C30, EORTC QLQ OES-18, EORTC OG-25 A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma NCT05370144NA1 site📍 Calgary AHS Cancer Control Alberta · Tests: Hypofractionated radiotherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy